The Therapeutic Potential of VEGF Inhibition in Diabetic Microvascular Complications

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.7, Iss.6, 2007-01, pp. : 393-398

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipoproteins and Diabetic Microvascular Complications

Current Pharmaceutical Design, Vol. 10, Iss. 27, 2004-10 ,pp. : 3395-3418

Bentham Science Publishers

Access to resources Recommend Favorite

Aldose Reductase in Diabetic Microvascular Complications

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 475-486

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetic Vascular Complications: Pathophysiology, Biochemical Basis and Potential Therapeutic Strategy

Current Pharmaceutical Design, Vol. 11, Iss. 18, 2005-07 ,pp. : 2279-2299

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Potential New Therapeutic Strategies of Diabetic Vascular Complications (Guest Editor: Toyoshi Inoguchi)]

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 445-446

Bentham Science Publishers

Access to resources Recommend Favorite

Pigment Epithelium-Derived Factor (PEDF): Its Potential Therapeutic Implication in Diabetic Vascular Complications

Current Drug Targets, Vol. 9, Iss. 11, 2008-11 ,pp. : 1025-1029

Bentham Science Publishers

Access to resources Recommend Favorite